Finasteride significantly reduces acute urinary retention and need for surgery in patients with symptomatic benign prostatic hyperplasia

Jens T. Andersen, J. Curtis Nickel, Villis R. Marshall, Claude C. Schulman, Peter Boyle

Research output: Contribution to journalArticle

106 Citations (Scopus)

Abstract

Objectives. A pooled analysis of all available randomized trials with 2-year follow-up data with finasteride and placebo was undertaken to further investigate recent observations that finasteride use may reduce the occurrence of acute urinary retention (AUR) and benign prostatic hyperplasia (BPH)-related surgical intervention. Methods. Occurrences of AUR and surgical intervention were examined by treatment group in a pooled series of 4222 men with moderately symptomatic BPH. Results. In total, 81 occurrences of AUR were reported, 24 (1.1%) of 2113 in the finasteride group and 57 (2.7%) of 2109 in the placebo group. The hazard ratio was consistent in all three studies, with a 57% decrease in the hazard rate for occurrence of AUR with finasteride compared with that for placebo present in the pooled data set over the 2-year study period (P
Original languageEnglish
Pages (from-to)839-845
Number of pages7
JournalUrology
Volume49
Issue number6
DOIs
Publication statusPublished - 1997

Fingerprint

Finasteride
Urinary Retention
Prostatic Hyperplasia
Placebos

Cite this

Andersen, Jens T. ; Curtis Nickel, J. ; Marshall, Villis R. ; Schulman, Claude C. ; Boyle, Peter. / Finasteride significantly reduces acute urinary retention and need for surgery in patients with symptomatic benign prostatic hyperplasia. In: Urology. 1997 ; Vol. 49, No. 6. pp. 839-845.
@article{e36f1f4ae8a44214bd0899965c593b05,
title = "Finasteride significantly reduces acute urinary retention and need for surgery in patients with symptomatic benign prostatic hyperplasia",
abstract = "Objectives. A pooled analysis of all available randomized trials with 2-year follow-up data with finasteride and placebo was undertaken to further investigate recent observations that finasteride use may reduce the occurrence of acute urinary retention (AUR) and benign prostatic hyperplasia (BPH)-related surgical intervention. Methods. Occurrences of AUR and surgical intervention were examined by treatment group in a pooled series of 4222 men with moderately symptomatic BPH. Results. In total, 81 occurrences of AUR were reported, 24 (1.1{\%}) of 2113 in the finasteride group and 57 (2.7{\%}) of 2109 in the placebo group. The hazard ratio was consistent in all three studies, with a 57{\%} decrease in the hazard rate for occurrence of AUR with finasteride compared with that for placebo present in the pooled data set over the 2-year study period (P",
author = "Andersen, {Jens T.} and {Curtis Nickel}, J. and Marshall, {Villis R.} and Schulman, {Claude C.} and Peter Boyle",
year = "1997",
doi = "10.1016/S0090-4295",
language = "English",
volume = "49",
pages = "839--845",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "6",

}

Finasteride significantly reduces acute urinary retention and need for surgery in patients with symptomatic benign prostatic hyperplasia. / Andersen, Jens T.; Curtis Nickel, J.; Marshall, Villis R.; Schulman, Claude C.; Boyle, Peter.

In: Urology, Vol. 49, No. 6, 1997, p. 839-845.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Finasteride significantly reduces acute urinary retention and need for surgery in patients with symptomatic benign prostatic hyperplasia

AU - Andersen, Jens T.

AU - Curtis Nickel, J.

AU - Marshall, Villis R.

AU - Schulman, Claude C.

AU - Boyle, Peter

PY - 1997

Y1 - 1997

N2 - Objectives. A pooled analysis of all available randomized trials with 2-year follow-up data with finasteride and placebo was undertaken to further investigate recent observations that finasteride use may reduce the occurrence of acute urinary retention (AUR) and benign prostatic hyperplasia (BPH)-related surgical intervention. Methods. Occurrences of AUR and surgical intervention were examined by treatment group in a pooled series of 4222 men with moderately symptomatic BPH. Results. In total, 81 occurrences of AUR were reported, 24 (1.1%) of 2113 in the finasteride group and 57 (2.7%) of 2109 in the placebo group. The hazard ratio was consistent in all three studies, with a 57% decrease in the hazard rate for occurrence of AUR with finasteride compared with that for placebo present in the pooled data set over the 2-year study period (P

AB - Objectives. A pooled analysis of all available randomized trials with 2-year follow-up data with finasteride and placebo was undertaken to further investigate recent observations that finasteride use may reduce the occurrence of acute urinary retention (AUR) and benign prostatic hyperplasia (BPH)-related surgical intervention. Methods. Occurrences of AUR and surgical intervention were examined by treatment group in a pooled series of 4222 men with moderately symptomatic BPH. Results. In total, 81 occurrences of AUR were reported, 24 (1.1%) of 2113 in the finasteride group and 57 (2.7%) of 2109 in the placebo group. The hazard ratio was consistent in all three studies, with a 57% decrease in the hazard rate for occurrence of AUR with finasteride compared with that for placebo present in the pooled data set over the 2-year study period (P

U2 - 10.1016/S0090-4295

DO - 10.1016/S0090-4295

M3 - Article

VL - 49

SP - 839

EP - 845

JO - Urology

JF - Urology

SN - 0090-4295

IS - 6

ER -